Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Has announcements × Purpura, Thrombocytopenic × Classical hematology × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Classical hematology 1

Conditions

Hemophilia A 4 Anemia, Sickle Cell 4 Thrombocytopenia 2 Anemia 2 Venous Thromboembolism 1 Vaso-Occlusive Crises 1 Renal Anemia 1 Purpura, Thrombocytopenic, Idiopathic 1 Purpura, Thrombocytopenic 1 Priapism 1 Ovarian Neoplasms 1 Myelodysplastic Syndromes 1 Leukemia, Lymphocytic, Chronic, B-Cell 1 Fanconi Anemia, Complementation Group D1 1

Interventions

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01444417 2017-02-09

Safety and Efficacy Study of Romiplostim to Treat Immune Thrombocytopenia (ITP) in Pediatric Patients

Amgen

Phase 3 Completed

62 enrolled 16 charts 1 FDA

Classical hematology

Purpura, Thrombocytopenic, Thrombocytopenia, Purpura, Thrombocytopenic, Idiopathic

Data powered by HemOnc (CC BY 4.0) Colophon ⚡